Table 2 Comparison of AMH and ultrasonic examination results across different groups.

From: Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone

Group

Healthy group

AM group

OEM group

F-value

P-value

AMH(ng/ml)

4.53 ± 1.13

3.78 ± 1.08a

1.25 ± 1.34ab

90.34

P <0.001

AFC

12.19 ± 3.37

8.05 ± 2.49a

2.53 ± 1.19ab

146.50

P <0.001

OV(cm³)

7.71 ± 1.68

6.15 ± 1.50a

3.30 ± 1.25ab

92.61

P <0.001

VI

4.62 ± 2.20

3.04 ± 1.64a

0.61 ± 0.80ab

63.87

P<0.001

FI

33.77 ± 4.77

30.28 ± 3.31a

24.05 ± 3.85ab

59.50

P<0.001

VFI

1.74 ± 1.07

1.02 ± 0.64a

0.17 ± 0.28ab

49.36

P<0.001

  1. The superscript ‘a’ indicates a significant difference compared to the Healthy group (P < 0.05).
  2. The superscript ‘b’ indicates a significant difference compared to the AM group (P < 0.05).
Back to article page